Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia.

The Open AIDS Journal Pub Date : 2017-04-26 eCollection Date: 2017-01-01 DOI:10.2174/1874613601711010032
Mehwish Younas, Christina Psomas, Vikram Mehraj, Renaud Cezar, Pierre Portales, Edouard Tuaillon, Adeline Guigues, Jacques Reynes, Pierre Corbeau, Jean-Pierre Routy
{"title":"Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia.","authors":"Mehwish Younas,&nbsp;Christina Psomas,&nbsp;Vikram Mehraj,&nbsp;Renaud Cezar,&nbsp;Pierre Portales,&nbsp;Edouard Tuaillon,&nbsp;Adeline Guigues,&nbsp;Jacques Reynes,&nbsp;Pierre Corbeau,&nbsp;Jean-Pierre Routy","doi":"10.2174/1874613601711010032","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Interleukin-33 (IL-33) is a cell damage-induced alarmin. The plasma concentration of suppression of tumorogenicity (sST2), a surrogate marker of IL-33 production, is a prognostic marker of cardiovascular disease.</p><p><strong>Observation: </strong>Recently, we reported that sST2 plasma levels were elevated in early HIV-1 infection and linked to markers of microbial translocation and of T cell activation.</p><p><strong>Results: </strong>Here we show that it is not the case in patients with suppressed viremia. Thus, IL-33 plays its alarmin role only during the early phase of the infection.</p>","PeriodicalId":515834,"journal":{"name":"The Open AIDS Journal","volume":"11 ","pages":"32-35"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427803/pdf/","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open AIDS Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874613601711010032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Introduction: Interleukin-33 (IL-33) is a cell damage-induced alarmin. The plasma concentration of suppression of tumorogenicity (sST2), a surrogate marker of IL-33 production, is a prognostic marker of cardiovascular disease.

Observation: Recently, we reported that sST2 plasma levels were elevated in early HIV-1 infection and linked to markers of microbial translocation and of T cell activation.

Results: Here we show that it is not the case in patients with suppressed viremia. Thus, IL-33 plays its alarmin role only during the early phase of the infection.

Abstract Image

慢性感染HIV-1病毒血症患者血浆可溶性ST2水平
白细胞介素-33 (IL-33)是一种细胞损伤诱导的报警蛋白。血浆抑瘤性浓度(sST2)是IL-33生成的替代标志物,是心血管疾病的预后标志物。观察:最近,我们报道了sST2血浆水平在早期HIV-1感染中升高,并与微生物易位和T细胞活化标志物有关。结果:在抑制性病毒血症患者中并非如此。因此,IL-33仅在感染的早期阶段起警示作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信